NHI Q3 Normalized FFO $1.32/share, up 28% YoY; raises full-year guidance third time

NATIONAL HEALTH INVESTORS INC

2025-Q3 EPS reported $2.22 revenue$269,805,000

Net income $0.69/diluted share vs $0.65 YoY; NAREIT FFO $1.09 vs $1.03.
Normalized FFO $1.32 vs $1.03 YoY driven by SHOP NOI growth of ~63%.
Raised 2025 NAREIT FFO guidance to $4.62-$4.65 from $4.46-$4.50; Normalized FFO to $4.88-$4.91.
Acquired four SHOP properties for $74.3M and a CCRC for $52.5M in October; pipeline $195M under LOI.
Net debt/adjusted EBITDA 3.6x; issued $350M 5.35% senior notes due 2033.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.